FSR: A Weaponized Regulation
The Context
On Monday, April 27, 2026, China’s National Development and Reform Commission (NDRC) issued a formal cancellation order. Meta’s $2 billion acquisition of Manus, announced in December 2025, was unwound. This is not a market correction. It is the first concrete enforcement action under a new policy: Chinese tech companies must now secure government approval before accepting US capital. The trigger was not price or competition. It was the transfer of an AI team, system, and operational know-how embedded in a Chinese-founded, Singapore-incorporated organization to a US acquirer. The Washington Post called it a “new red line.” The Ministry of Commerce framed the probe around export control laws and a single statutory question: is an AI team an export? The answer, apparently, is yes.
The Risk
For directors of any Western firm with Chinese exposure, this is a direct liability signal. The Companies Act 1993 imposes a duty of care, diligence, and skill on directors. If your organisation holds investments, joint ventures, or acquisition targets that could be deemed a “transfer of Chinese-trained intellectual property,” you may be personally exposed. The NDRC’s review mechanism is now a genuine deal risk. Consider the consequences for Meta: potential inability to integrate or retain the Manus team, uncertain prospects for recovering the $2 billion consideration, and required resolution through legal proceedings rather than negotiation. This is not a hypothetical. The statutory framework in China now treats an AI team as a controlled export. If your board approved a transaction that could be retroactively blocked, and you failed to assess this regulatory risk, you may have breached your duty under section 137 of the Companies Act. The penalties? Unlimited fines, disqualification, and in severe cases, personal liability for the loss. The legal precedent is being written now.
The Control
The strategic solution is not to avoid China. It is to build a regulatory firewall. Your board must demand a formal Foreign Investment Security Review (FSR) risk assessment for every proposed acquisition, joint venture, or technology transfer involving a Chinese-founded entity, regardless of its incorporation jurisdiction. This assessment must be documented, stress-tested, and updated quarterly. The cost of non-compliance is not just a blocked deal—it is a frozen asset, a stranded investment, and a personal liability action.
The Challenge
These are the critical questions you should be raising at the board table:
| Does our current due diligence process include a specific assessment of whether a target’s team, codebase, or training data could be classified as a “controlled export” under Chinese law? | |
| What is our contingency plan if the NDRC retroactively blocks a transaction we have already completed, including the legal and financial mechanisms to recover consideration? | |
| Have we formally documented, in board minutes, our assessment of the FSR risk for every current Chinese-linked investment, and do we have a legal opinion from a qualified PRC counsel confirming our exposure? |